Nine in 10 Voters Express Concern That Medicare Lab Payment Cuts Will Harm Patient Access to Diagnostic Lab Testing, Finds National Survey from Quest Diagnostics
Go back to Nine in 10 Voters Express Concern That Medicare Lab Payment Cuts Will Harm Patient Access to Diagnostic Lab Testing, Finds National Survey from Quest Diagnostics| Quest Diagnostics (NYSE: DGX) | Delayed: 238.93 +1.81 (0.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $237.12 | 52 Week High | $86.85 | |||
| Open | $235.34 | 52 Week Low | $59.66 | |||
| Day High | $240.56 | P/E | 45.00 | |||
| Day Low | $223.50 | EPS | $5.31 | |||
| Volume | 1,205,052 | |||||



